MORGAN STANLEY - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 53 filers reported holding ENZO BIOCHEM INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$105,895
-14.9%
75,639
+11.8%
0.00%
Q2 2023$124,456
-70.0%
67,639
-60.4%
0.00%
Q1 2023$415,239
-20.9%
170,880
-53.5%
0.00%
Q4 2022$525,242
-39.4%
367,302
-5.6%
0.00%
Q3 2022$867,000
-0.5%
389,198
-7.5%
0.00%
Q2 2022$871,000
-38.5%
420,756
-13.8%
0.00%
Q1 2022$1,416,000
+2260.0%
488,175
+2482.5%
0.00%
Q4 2021$60,000
+36.4%
18,903
+54.4%
0.00%
Q3 2021$44,000
+2.3%
12,246
-9.6%
0.00%
Q2 2021$43,000
+53.6%
13,551
+66.9%
0.00%
Q1 2021$28,000
-72.8%
8,119
-80.0%
0.00%
Q4 2020$103,000
+312.0%
40,649
+241.3%
0.00%
Q3 2020$25,000
-35.9%
11,911
-32.7%
0.00%
Q2 2020$39,000
+105.3%
17,698
+146.2%
0.00%
Q1 2020$19,000
-94.9%
7,189
-94.9%
0.00%
Q4 2019$373,000
+9.4%
141,724
+49.6%
0.00%
Q3 2019$341,000
+60.1%
94,711
+49.6%
0.00%
Q2 2019$213,000
+10.4%
63,325
-10.3%
0.00%
Q1 2019$193,000
-56.8%
70,586
-56.1%
0.00%
Q4 2018$447,000
-39.8%
160,682
-10.8%
0.00%
Q3 2018$742,000
-37.2%
180,071
-20.9%
0.00%
Q2 2018$1,182,000
-31.8%
227,721
-28.0%
0.00%
Q1 2018$1,732,000
+2.5%
316,146
+52.6%
0.00%
Q4 2017$1,689,000
+22.4%
207,202
+57.1%
0.00%
Q3 2017$1,380,000
+115.6%
131,929
+127.2%
0.00%
Q2 2017$640,000
-40.4%
58,072
-54.7%
0.00%
Q1 2017$1,074,000
-48.7%
128,296
-57.4%
0.00%
Q4 2016$2,094,000
+731.0%
301,472
+508.2%
0.00%
Q3 2016$252,000
-44.4%
49,568
-34.7%
0.00%
Q2 2016$453,000
-18.8%
75,944
-38.1%
0.00%
Q1 2016$558,000
+27.7%
122,653
+26.2%
0.00%
Q4 2015$437,000
+50.7%
97,218
+6.5%
0.00%
Q3 2015$290,000
-3.7%
91,262
-8.1%
0.00%
Q2 2015$301,000
-56.9%
99,302
-58.1%
0.00%
Q1 2015$699,000
-50.3%
237,008
-25.2%
0.00%
-100.0%
Q4 2014$1,406,000
+0.8%
316,674
+16.9%
0.00%0.0%
Q3 2014$1,395,000
+13.3%
270,926
+15.6%
0.00%
Q2 2014$1,231,000
+541.1%
234,438
+407.4%
0.00%
Q1 2014$192,000
-38.7%
46,200
-56.8%
0.00%
Q4 2013$313,000
+8.3%
106,871
-6.9%
0.00%
Q3 2013$289,000
+33.2%
114,746
+9.8%
0.00%
Q2 2013$217,000104,4610.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2022
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 3,312,792$22,991,0004.49%
First Light Asset Management, LLC 1,007,357$6,991,0003.07%
KOPP INVESTMENT ADVISORS LLC 211,974$1,471,0001.55%
GLOBEFLEX CAPITAL L P 223,931$1,554,0000.39%
Nine Chapters Capital Management LLC 30,900$214,0000.36%
KEMPNER CAPITAL MANAGEMENT INC. 70,001$486,0000.35%
Campbell & CO Investment Adviser LLC 11,513$80,0000.25%
EAM Investors, LLC 259,914$1,804,0000.24%
Teza Capital Management LLC 14,636$102,0000.14%
Acrospire Investment Management LLC 46,220$321,0000.13%
View complete list of ENZO BIOCHEM INC shareholders